Pitcairn’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,759
| Closed | -$585K | – | 141 |
|
|
2025
Q3 | $585K | Sell |
7,759
-550
| -7% | -$37.7K | 0.05% | 317 |
|
|
2025
Q2 | $573K | Sell |
8,309
-94
| -1% | -$6.16K | 0.04% | 377 |
|
|
2025
Q1 | $569K | Buy |
8,403
+1,072
| +15% | +$64.2K | 0.03% | 392 |
|
|
2024
Q4 | $329K | Sell |
7,331
-267
| -4% | -$15K | 0.02% | 558 |
|
|
2024
Q3 | $478K | Sell |
7,598
-11,556
| -60% | -$674K | 0.03% | 460 |
|
|
2024
Q2 | $1.13M | Sell |
19,154
-24,452
| -56% | -$1.53M | 0.07% | 250 |
|
|
2024
Q1 | $3.48M | Buy |
43,606
+2,280
| +6% | +$174K | 0.23% | 83 |
|
|
2023
Q4 | $3.26M | Sell |
41,326
-290
| -0.7% | -$20.6K | 0.24% | 83 |
|
|
2023
Q3 | $2.91M | Buy |
41,616
+2,363
| +6% | +$167K | 0.24% | 76 |
|
|
2023
Q2 | $2.71M | Buy |
39,253
+2,294
| +6% | +$163K | 0.23% | 85 |
|
|
2023
Q1 | $2.75M | Buy |
36,959
+605
| +2% | +$50.7K | 0.25% | 77 |
|
|
2022
Q4 | $3.39M | Buy |
36,354
+289
| +0.8% | +$27.9K | 0.34% | 53 |
|
|
2022
Q3 | $3.44M | Buy |
36,065
+552
| +2% | +$54.6K | 0.37% | 48 |
|
|
2022
Q2 | $3.29M | Sell |
35,513
-465
| -1% | -$45.4K | 0.35% | 47 |
|
|
2022
Q1 | $3.64M | Sell |
35,978
-594
| -2% | -$62.4K | 0.32% | 55 |
|
|
2021
Q4 | $3.77M | Buy |
36,572
+1,115
| +3% | +$103K | 0.24% | 62 |
|
|
2021
Q3 | $3.01M | Sell |
35,457
-264
| -0.7% | -$22.1K | 0.21% | 68 |
|
|
2021
Q2 | $2.98M | Buy |
35,721
+287
| +0.8% | +$23.5K | 0.2% | 68 |
|
|
2021
Q1 | $2.67M | Buy |
35,434
+5,525
| +18% | +$402K | 0.19% | 77 |
|
|
2020
Q4 | $2.04M | Buy |
29,909
+399
| +1% | +$26K | 0.16% | 93 |
|
|
2020
Q3 | $1.72M | Sell |
29,510
-3,628
| -11% | -$226K | 0.15% | 97 |
|
|
2020
Q2 | $2.15M | Buy |
33,138
+3,831
| +13% | +$241K | 0.21% | 74 |
|
|
2020
Q1 | $1.74M | Buy |
29,307
+6,511
| +29% | +$435K | 0.21% | 74 |
|
|
2019
Q4 | $1.69M | Buy |
22,796
+1,872
| +9% | +$131K | 0.16% | 88 |
|
|
2019
Q3 | $1.32M | Buy |
20,924
+769
| +4% | +$45.6K | 0.13% | 102 |
|
|
2019
Q2 | $1.1M | Buy |
20,155
+7,906
| +65% | +$426K | 0.11% | 118 |
|
|
2019
Q1 | $661K | Buy |
12,249
+1,847
| +18% | +$114K | 0.07% | 176 |
|
|
2018
Q4 | $682K | Buy |
10,402
+757
| +8% | +$56.5K | 0.08% | 150 |
|
|
2018
Q3 | $760K | Buy |
9,645
+728
| +8% | +$52K | 0.08% | 165 |
|
|
2018
Q2 | $574K | Sell |
8,917
-611
| -6% | -$40.3K | 0.06% | 226 |
|
|
2018
Q1 | $592K | Sell |
9,528
-1,176
| -11% | -$84.4K | 0.06% | 213 |
|
|
2017
Q4 | $776K | Sell |
10,704
-1,240
| -10% | -$90.2K | 0.08% | 176 |
|
|
2017
Q3 | $971K | Buy |
11,944
+2,623
| +28% | +$207K | 0.11% | 132 |
|
|
2017
Q2 | $750K | Buy |
9,321
+480
| +5% | +$37.9K | 0.09% | 163 |
|
|
2017
Q1 | $694K | Buy |
8,841
+511
| +6% | +$40.8K | 0.08% | 186 |
|
|
2016
Q4 | $657K | Sell |
8,330
-5,175
| -38% | -$419K | 0.08% | 184 |
|
|
2016
Q3 | $1.2M | Sell |
13,505
-592
| -4% | -$55.9K | 0.15% | 106 |
|
|
2016
Q2 | $1.35M | Buy |
14,097
+2,822
| +25% | +$281K | 0.17% | 92 |
|
|
2016
Q1 | $1.17M | Sell |
11,275
-10
| -0.1% | -$972 | 0.15% | 117 |
|
|
2015
Q4 | $1.1M | Sell |
11,285
-104
| -0.9% | -$10.2K | 0.12% | 128 |
|
|
2015
Q3 | $1.1M | Buy |
11,389
+1,403
| +14% | +$147K | 0.15% | 119 |
|
|
2015
Q2 | $1.05M | Sell |
9,986
-409
| -4% | -$41.8K | 0.12% | 138 |
|
|
2015
Q1 | $1.07M | Buy |
10,395
+528
| +5% | +$53.4K | 0.12% | 140 |
|
|
2014
Q4 | $951K | Sell |
9,867
-176
| -2% | -$15.5K | 0.1% | 154 |
|
|
2014
Q3 | $799K | Sell |
10,043
-90
| -0.9% | -$7.09K | 0.09% | 174 |
|
|
2014
Q2 | $764K | Sell |
10,133
-465
| -4% | -$35.1K | 0.08% | 189 |
|
|
2014
Q1 | $793K | Sell |
10,598
-9,038
| -46% | -$638K | 0.09% | 182 |
|
|
2013
Q4 | $1.41M | Buy |
19,636
+459
| +2% | +$29.5K | 0.16% | 116 |
|
|
2013
Q3 | $1.09M | Sell |
19,177
-1,416
| -7% | -$84.4K | 0.13% | 134 |
|
|
2013
Q2 | $1.18M | Buy |
+20,593
| New | +$1.19M | 0.16% | 128 |
|
Other funds holding CVS
Pitcairn's CVS Position: Q4 2025 in Review
Pitcairn sold out of CVS Health (CVS) in Q4 2025, closing a stake of 7,759 shares — an estimated $585K sold.
Pitcairn first reported a position in CVS in Q2 2013 and held it in 50 quarters. The position peaked at $3.77M in Q4 2021. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Pitcairn reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 7,759 CVS Health shares in Q4 2025, an estimated $585K.
- Pitcairn first reported a position in CVS Health in Q2 2013 and held it in 50 quarters.
- Pitcairn's CVS Health position peaked at $3.77M in Q4 2021.
- 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.